Open beta · everything is free with an account while we build. Founding accounts get preferred pricing when paid plans arrive. Create yours →
JF

JESSICA FRIEND

GENENTECH, INC · WASHINGTON, DC
Registered · LDAActive

At a glance

Works on
Professional highlights appear here once this profile is claimed. Claim it →

Background

Career
WASHINGTON, DC · current

The past 12 months

Clients
1
past 12 months
Filings
3
past 12 months
Agencies contacted
HOUSE OF REPRESENTATIVESHealth & Human Services, Dept of (HHS)SENATE

Specific issues

Issues related to the 340B Drug Discount Program Issues relating to drug pricing Development of policies to advance antimicrobial research, antiviral research, and novel product development environment, including advancing new market incentives. Issues and policies relating to the Food and Drug Administration including biopharmaceutical development, drug safety and counterfeiting, and biosimilars. General education about policies impacting pharmaceutical development, approval, reimbursement and pricing. Issues related to healthcare legislation Patient access to Part B medicines Issues related to health equity, diversity, and inclusion in clinical trials Issues related to advanced development and procurement of medical countermeasures (MCMs) Issues related to patient assistance and access Issues relating to privacy and securing the data of and personal information of consumers Issues relating to medical research data Issues relating to screening and diagnostics Issues related to public health preparedness and response Issues related to awareness about diabetic eye diseases in minority populations Issues related to public health preparedness. Issues related to access to drugs for minority communities Issues related to healthcare education and screening
Health Issues · 2026 Q2

Clients

2026 · 3 filings
$██,███ / qtrFree in beta

Sources

This profile is built from the public record: filings in the U.S. Senate Lobbying Disclosure Act system. lda.senate.gov ↗

Recent filings3
2026 Q2
GENENTECH INC
Q2lda.gov →
2026 Q1
GENENTECH INC
Q1lda.gov →
2026 Q1
GENENTECH INC
1Alda.gov →